Project Details
Description
Phase II Study of Panobinostat (LBH589) Given In Combination With Bortezomib (Velcade) In Patients With Pancreatic Cancer Progressing On Gemcitabine Therapy Alone Or Gemcitabine In Combination
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/07 → 6/30/12 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.